USP16 and monocytic leukemia: In doing so, the authors found that the human monocytic leukemia THP-1 cell line can develop alternative pathways to escape the inactivation mutations of USP16, suggesting that the function of USP16 is potentially redundant, and another unstudied DUB may compensate for the loss of function.